R&D News | pharmaphorum

News

AI specialist Recursion nabs multibillion-dollar Roche partn...

Roche has formed a decade-long alliance with Recursion Pharma that will focus on using machine learning and "industrialised" drug discovery to find new neuroscience and cancer drugs.

News

Merck halts more trials of HIV candidate islatravir

Merck & Co has halted enrolment in a pair of phase 3 trials of its experimental HIV drug islatravir, raising another warning flag about the highly-touted therapy.

News

Viagra 'should be tested as Alzheimer's therapy'

Scientists in the US have found that people who use Viagra for erectile dysfunction seem to have a lower risk of developing Alzheimer's disease – a link that they say should be examined mor

News

Close Up Of Senior Man Suffering With Parkinsons Diesease

Novartis takes aim at risky Parkinson's target with $1.5bn U...

Novartis has licensed a potential drug for Parkinson's from Belgium's UCB that it thinks could be the first oral, disease-modifying drug for the disease – if it can avoid the fate of earlie

News

GSK pumps £30m into a new Oxford University partnership

GlaxoSmithKline has formed a five-year partnership with Oxford University to set up a new institute that will apply machine learning and functional genomics to the discovery of new medicine

News

engineering and genetic editing through the Crispr technique. DNA chain breaking down. 3D rendering

Dyno attracts $1.6bn gene therapy deal with Astellas

Astellas has signed another bolt-on deal to build its gene therapy pipeline, agreeing a deal with Dyno Therapeutics to tap into its adeno-associated virus (AAV) vector platform for deliveri

AI specialist Recursion nabs multibillion-dollar Roche partn...

Merck halts more trials of HIV candidate islatravir

Viagra 'should be tested as Alzheimer's therapy'

Novartis takes aim at risky Parkinson's target with $1.5bn U...

GSK pumps £30m into a new Oxford University partnership

Dyno attracts $1.6bn gene therapy deal with Astellas

Danco fights back after US court curbs abortion pill access

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks